Litcius/Paper detail

Multi-modal deep learning based on multi-dimensional and multi-level temporal data can enhance the prognostic prediction for multi-drug resistant pulmonary tuberculosis patients

Zhenhui Lu, Ming Yang, Chenhui Pan, Peiyong Zheng, Shun-Xian Zhang

2022Science in One Health14 citationsDOIOpen Access PDF

Abstract

Despite the advent of new diagnostics, drugs and regimens, multi-drug resistant pulmonary tuberculosis (MDR-PTB) remains a global health threat. It has a long treatment cycle, low cure rate and heavy disease burden. Factors such as demographics, disease characteristics, lung imaging, biomarkers, therapeutic schedule and adherence to medications are associated with MDR-PTB prognosis. However, thus far, the majority of existing studies have focused on predicting treatment outcomes through static single-scale or low dimensional information. Hence, multi-modal deep learning based on dynamic data for multiple dimensions can provide a deeper understanding of personalized treatment plans to aid in the clinical management of patients.

Topics & Concepts

MedicineDemographicsIntensive care medicineCure ratePulmonary tuberculosisBig dataDiseasePulmonary diseaseModalInternal medicineTuberculosisData miningComputer sciencePathologySociologyDemographyPolymer chemistryChemistryTuberculosis Research and EpidemiologyCOVID-19 diagnosis using AIPneumonia and Respiratory Infections
Multi-modal deep learning based on multi-dimensional and multi-level temporal data can enhance the prognostic prediction for multi-drug resistant pulmonary tuberculosis patients | Litcius